A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.
Pearse M, Fraser-Browne C, Davis ID, Duchesne GM, Fisher R, Frydenberg M, Haworth A, Jose C, Joseph DJ, Lim TS, Matthews J, Millar J, Sidhom M, Spry NA, Tang CI, Turner S, Williams SG, Wiltshire K, Woo HH, Kneebone A.
Pearse M, et al. Among authors: millar j.
BJU Int. 2014 Mar;113 Suppl 2:7-12. doi: 10.1111/bju.12623.
BJU Int. 2014.
PMID: 24894850
Clinical Trial.